[go: up one dir, main page]

GB9803447D0 - Cancer diagnosis - Google Patents

Cancer diagnosis

Info

Publication number
GB9803447D0
GB9803447D0 GBGB9803447.3A GB9803447A GB9803447D0 GB 9803447 D0 GB9803447 D0 GB 9803447D0 GB 9803447 A GB9803447 A GB 9803447A GB 9803447 D0 GB9803447 D0 GB 9803447D0
Authority
GB
United Kingdom
Prior art keywords
cancer diagnosis
diagnosis
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9803447.3A
Other versions
GB2334578A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Liverpool
Original Assignee
University of Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Liverpool filed Critical University of Liverpool
Priority to GB9803447A priority Critical patent/GB2334578A/en
Publication of GB9803447D0 publication Critical patent/GB9803447D0/en
Priority to GB9814545A priority patent/GB2334579B/en
Priority to PCT/GB1999/000503 priority patent/WO1999042828A2/en
Priority to PCT/GB1999/000512 priority patent/WO1999042839A2/en
Priority to AU26301/99A priority patent/AU2630199A/en
Priority to JP2000532728A priority patent/JP2002504354A/en
Priority to AT99905084T priority patent/ATE238555T1/en
Priority to AU25385/99A priority patent/AU753588B2/en
Priority to CA002321479A priority patent/CA2321479A1/en
Priority to PCT/GB1999/000500 priority patent/WO1999042834A2/en
Priority to AT99905083T priority patent/ATE238554T1/en
Priority to AU25381/99A priority patent/AU735896B2/en
Priority to JP2000532725A priority patent/JP2002504687A/en
Priority to AT99905082T priority patent/ATE238553T1/en
Priority to DE69907156T priority patent/DE69907156T2/en
Priority to AU25380/99A priority patent/AU739001B2/en
Priority to CA002321480A priority patent/CA2321480A1/en
Priority to PCT/GB1999/000501 priority patent/WO1999042835A1/en
Priority to AT99905087T priority patent/ATE238557T1/en
Priority to AU25382/99A priority patent/AU741712B2/en
Priority to EP99905086A priority patent/EP1057031B1/en
Priority to AU25384/99A priority patent/AU741632B2/en
Priority to EP99905081A priority patent/EP1057027A2/en
Priority to CA002321438A priority patent/CA2321438A1/en
Priority to EP99905083A priority patent/EP1057029B1/en
Priority to PCT/GB1999/000506 priority patent/WO1999042821A2/en
Priority to AT99906326T priority patent/ATE238558T1/en
Priority to CA002321467A priority patent/CA2321467A1/en
Priority to CA002321482A priority patent/CA2321482A1/en
Priority to EP99905082A priority patent/EP1057028B1/en
Priority to PCT/GB1999/000505 priority patent/WO1999042836A1/en
Priority to DE69907153T priority patent/DE69907153T2/en
Priority to JP2000532726A priority patent/JP2002504496A/en
Priority to DE69907151T priority patent/DE69907151D1/en
Priority to JP2000532712A priority patent/JP2002504683A/en
Priority to AT99905086T priority patent/ATE238556T1/en
Priority to EP99905084A priority patent/EP1057030B1/en
Priority to CA002321481A priority patent/CA2321481A1/en
Priority to DE69907152T priority patent/DE69907152D1/en
Priority to CA002321458A priority patent/CA2321458A1/en
Priority to DE69907154T priority patent/DE69907154T2/en
Priority to EP99905087A priority patent/EP1057032B1/en
Priority to EP99906326A priority patent/EP1057033B1/en
Priority to US09/622,277 priority patent/US6521407B1/en
Priority to JP2000532719A priority patent/JP2002504353A/en
Priority to JP2000532727A priority patent/JP2002504688A/en
Priority to AU26300/99A priority patent/AU749180B2/en
Priority to DE69907155T priority patent/DE69907155T2/en
Priority to US09/622,577 priority patent/US6878526B1/en
Priority to PCT/GB1999/000509 priority patent/WO1999042837A1/en
Priority to AU25379/99A priority patent/AU743454B2/en
Priority to JP2000532107A priority patent/JP2002503822A/en
Priority to PCT/GB1999/000502 priority patent/WO1999042090A2/en
Publication of GB2334578A publication Critical patent/GB2334578A/en
Priority to US10/321,555 priority patent/US20030134315A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB9803447A 1998-02-18 1998-02-18 Diagnosis of cancer involving assay of levels of cyclin-dependent kinase (CDK) isoenzymes Withdrawn GB2334578A (en)

Priority Applications (54)

Application Number Priority Date Filing Date Title
GB9803447A GB2334578A (en) 1998-02-18 1998-02-18 Diagnosis of cancer involving assay of levels of cyclin-dependent kinase (CDK) isoenzymes
GB9814545A GB2334579B (en) 1998-02-18 1998-07-03 Treating cancer
PCT/GB1999/000503 WO1999042828A2 (en) 1998-02-18 1999-02-18 Treating cancer
PCT/GB1999/000512 WO1999042839A2 (en) 1998-02-18 1999-02-18 Treating cancer
AU26301/99A AU2630199A (en) 1998-02-18 1999-02-18 Treating cancer
JP2000532728A JP2002504354A (en) 1998-02-18 1999-02-18 Cancer Treatment
AT99905084T ATE238555T1 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
AU25385/99A AU753588B2 (en) 1998-02-18 1999-02-18 Treating cancer
CA002321479A CA2321479A1 (en) 1998-02-18 1999-02-18 Treating cancer
PCT/GB1999/000500 WO1999042834A2 (en) 1998-02-18 1999-02-18 Treating cancer
AT99905083T ATE238554T1 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
AU25381/99A AU735896B2 (en) 1998-02-18 1999-02-18 Treating cancer
JP2000532725A JP2002504687A (en) 1998-02-18 1999-02-18 Cancer Treatment
AT99905082T ATE238553T1 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
DE69907156T DE69907156T2 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
AU25380/99A AU739001B2 (en) 1998-02-18 1999-02-18 Treating cancer
CA002321480A CA2321480A1 (en) 1998-02-18 1999-02-18 Treating cancer
PCT/GB1999/000501 WO1999042835A1 (en) 1998-02-18 1999-02-18 Treating cancer
AT99905087T ATE238557T1 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
AU25382/99A AU741712B2 (en) 1998-02-18 1999-02-18 Treating cancer
EP99905086A EP1057031B1 (en) 1998-02-18 1999-02-18 Treating cancer
AU25384/99A AU741632B2 (en) 1998-02-18 1999-02-18 Treating cancer
EP99905081A EP1057027A2 (en) 1998-02-18 1999-02-18 Treating cancer
CA002321438A CA2321438A1 (en) 1998-02-18 1999-02-18 Treating cancer
EP99905083A EP1057029B1 (en) 1998-02-18 1999-02-18 Treating cancer
PCT/GB1999/000506 WO1999042821A2 (en) 1998-02-18 1999-02-18 Treating cancer
AT99906326T ATE238558T1 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
CA002321467A CA2321467A1 (en) 1998-02-18 1999-02-18 Treating cancer
CA002321482A CA2321482A1 (en) 1998-02-18 1999-02-18 Treating cancer
EP99905082A EP1057028B1 (en) 1998-02-18 1999-02-18 Treating cancer
PCT/GB1999/000505 WO1999042836A1 (en) 1998-02-18 1999-02-18 Treating cancer
DE69907153T DE69907153T2 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
JP2000532726A JP2002504496A (en) 1998-02-18 1999-02-18 Cancer Treatment
DE69907151T DE69907151D1 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
JP2000532712A JP2002504683A (en) 1998-02-18 1999-02-18 Cancer Treatment
AT99905086T ATE238556T1 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
EP99905084A EP1057030B1 (en) 1998-02-18 1999-02-18 Treating cancer
CA002321481A CA2321481A1 (en) 1998-02-18 1999-02-18 Treating cancer
DE69907152T DE69907152D1 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
CA002321458A CA2321458A1 (en) 1998-02-18 1999-02-18 Treating cancer
DE69907154T DE69907154T2 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
EP99905087A EP1057032B1 (en) 1998-02-18 1999-02-18 Treating cancer
EP99906326A EP1057033B1 (en) 1998-02-18 1999-02-18 Treating cancer
US09/622,277 US6521407B1 (en) 1998-02-18 1999-02-18 Methods for determining chemosensitivity of cancer cells based upon expression of negative and positive signal transduction factors
JP2000532719A JP2002504353A (en) 1998-02-18 1999-02-18 Cancer Treatment
JP2000532727A JP2002504688A (en) 1998-02-18 1999-02-18 Cancer Treatment
AU26300/99A AU749180B2 (en) 1998-02-18 1999-02-18 Treating cancer
DE69907155T DE69907155T2 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
US09/622,577 US6878526B1 (en) 1998-02-18 1999-02-18 Treating cancer
PCT/GB1999/000509 WO1999042837A1 (en) 1998-02-18 1999-02-18 Treating cancer
AU25379/99A AU743454B2 (en) 1998-02-18 1999-02-18 Treating cancer
JP2000532107A JP2002503822A (en) 1998-02-18 1999-02-18 Cancer Treatment
PCT/GB1999/000502 WO1999042090A2 (en) 1998-02-18 1999-02-18 Treating cancer
US10/321,555 US20030134315A1 (en) 1998-02-18 2002-12-18 Treating cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9803447A GB2334578A (en) 1998-02-18 1998-02-18 Diagnosis of cancer involving assay of levels of cyclin-dependent kinase (CDK) isoenzymes

Publications (2)

Publication Number Publication Date
GB9803447D0 true GB9803447D0 (en) 1998-04-15
GB2334578A GB2334578A (en) 1999-08-25

Family

ID=10827212

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9803447A Withdrawn GB2334578A (en) 1998-02-18 1998-02-18 Diagnosis of cancer involving assay of levels of cyclin-dependent kinase (CDK) isoenzymes

Country Status (1)

Country Link
GB (1) GB2334578A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE393821T1 (en) * 2001-02-14 2008-05-15 Sysmex Corp METHOD FOR DETERMINING CELL CYCLE REGULATORY FACTOR ACTIVITY AND METHOD FOR DIAGNOSING CANCER USING THE SAME
US7957910B2 (en) 2005-01-31 2011-06-07 Sysmex Corporation Method for predicting effectiveness of chemotherapy
US7682785B2 (en) * 2005-06-30 2010-03-23 Sysmex Corporation Method for predicting effectiveness of chemotherapy using anticancer agent
DE602006001701D1 (en) 2005-08-01 2008-08-21 Sysmex Corp Method for assessing the condition of malignant tumors
US9408848B2 (en) * 2008-08-15 2016-08-09 Georgetown University Fluorescent CDK inhibitors for treatment of cancer
EP2958584A1 (en) * 2013-02-20 2015-12-30 Yeda Research and Development Co., Ltd. Interferon treatment targeting mutant p53 expressing cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6593196A (en) * 1995-07-20 1997-02-18 Paracelsian, Inc. Determination of the presence of abnormal cellular proliferation through the detection of one or more cyclin dependent kinases

Also Published As

Publication number Publication date
GB2334578A (en) 1999-08-25

Similar Documents

Publication Publication Date Title
GB9807302D0 (en) Endoscope
AU136994S (en) Section
HUP0104857A3 (en) New cancer treatments
AU142196S (en) Tissue
GB2327497B (en) Diagnostic assay for cancer
GB2342462B (en) An endoscope
GB2339924B (en) Endoscope
GB9805877D0 (en) Cancer
GB9800534D0 (en) Diagnostic system
AU142195S (en) Tissue
GB9926805D0 (en) Diagnostic methods
GB9803447D0 (en) Cancer diagnosis
GB9909413D0 (en) Endoscope assembly
AU140956S (en) Tissue
GB9809730D0 (en) Endoscope assembly
GB9704876D0 (en) Diagnostic methods
GB9804361D0 (en) Cancer treatment
GB9924717D0 (en) Diagnostic
EP1140120A4 (en) Human brainiac-5
AU142197S (en) Tissue
GB9827102D0 (en) New cancer treatments
GB9826367D0 (en) Organism
GB9804050D0 (en) Cancer
GB9802420D0 (en) Skin cancer alleviator
GB9820000D0 (en) Cancer treatment

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)